Anne Kantardjieff, Ph.D.


Late Stage Process Development

Alexion Pharmaceuticals, Inc.

Dr. Anne Kantardjieff is currently Director of Late Stage Process Development at Alexion Pharmaceuticals, a company focused on treating rare diseases.  Prior to this role, she was Associate Director of Purification Development at Alexion and began her career there as a scientist in the Upstream Development group.  She has served as the Industrial Program Chair for the 2015 ACS BIOT national meeting, and is currently secretary for the ACS BIOT division.  She has co-authored several scientific papers, served as editor for two biotechnology books and presented at various conferences.  Dr. Kantardjieff graduated with a Ph.D. from the University of Minnesota’s Chemical Engineering program in 2009.  She previously received a bachelor’s degree in Chemical Engineering from McGill University in Montreal, Canada.